Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Tysabri 300mg Injection
Manufacturer/Marketed By : BIOGEN IDEC BIOTECH INDIA PVT LTD
$1157.51 $926.01
Tysabri 300mg injection contains an active component such as Natalizumab. This medication is a monoclonal antibody medication used to treat multiple sclerosis (MS) and Crohn's disease. Multiple sclerosis (MS) is...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
NATALIZUMAB
Active Pharmaceutical Ingredient
Tysabri 300mg Injection
$1,157.51
$926.01
Tysabri 300mg injection contains an active component such as Natalizumab. This medication is a monoclonal antibody medication used to treat multiple sclerosis (MS) and Crohn's disease. Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system, causing communication problems between the brain and the rest of the body. Crohn's disease is a chronic inflammatory condition affecting the gastrointestinal tract. This medication-targeted mechanism of action reduces inflammation by blocking specific immune cell movement, thereby mitigating potential damage to the central nervous system in MS or reducing inflammation in the gut in Crohn's disease. By effectively managing disease activity, Tysabri 300mg injection can improve patients' overall quality of life by reducing symptoms, decreasing the frequency of relapses, and potentially delaying disability progression. Tysabri 300mg injection can cause hypersensitivity reactions in some individuals. Patients with a history of hypersensitivity to this medicine or its components should avoid its use, and individuals at higher risk need screening. This medication is contraindicated in patients with a history of progressive multifocal leukoencephalopathy (PML) or who are positive for the JC virus, as they are at a higher risk of developing PML during treatment. It should not be used in patients with active infections, especially serious or opportunistic infections. Its safety and effectiveness in pediatric patients (children and adolescents) have not been fully established. Therefore, its use in this population is generally not recommended.
Active Pharmaceutical Ingredient
Uses
• Multiple sclerosis (MS)
• Crohn's disease.
Benefits
Tysabri 300mg injection is a monoclonal antibody that works by targeting a protein called α4-integrin on certain immune cells. By binding to α4-integrin, it prevents these immune cells from crossing the blood-brain barrier in multiple sclerosis or migrating into the gut lining in Crohn's disease. This action reduces inflammation and helps protect the central nervous system in MS, leading to fewer relapses and slowed disease progression. Overall, its mechanism of action modulates the immune response, providing therapeutic benefits in treating multiple sclerosis and Crohn's disease.
Side Effects
Tysabri 300mg injection causes some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Headache
• Fatigue
• Nausea
• Upper respiratory tract infections (common cold)
• Urinary tract infections
Common Side Effects
• Progressive multifocal leukoencephalopathy (PML)
• Infusion reactions
• Liver damage
• Infections
• Hypersensitivity
How To Use
Tysabri 300mg injection should be taken exactly as prescribed by a healthcare professional. The route of administration for this medication is intravenous (IV) infusion. The medication is delivered directly into the bloodstream through a vein. It is not available in oral form or as a subcutaneous injection.
Safety Advice
• Breast Feeding: The safety of Tysabri 300mg injection during breastfeeding is not fully established, and the healthcare provider will provide personalized advice to make an informed decision regarding the use of the medication during this period, considering the well-being of both the mother and the baby.
• Alcohol: Limit alcohol consumption and consult your healthcare provider for personalized advice regarding alcohol use while taking Tysabri 300mg injection.
• Liver: If you have liver-related medical conditions, such as liver disease or liver dysfunction, it is crucial to inform your healthcare provider about your condition before starting Tysabri 300mg injection or any other medication.
• Lungs: Patients taking Tysabri 300mg injection should promptly report any respiratory symptoms to their healthcare provider and adhere to prescribed treatments to manage their underlying condition effectively.
• Driving: During treatment with Tysabri 300mg injection, patients should exercise caution when driving, as the medication may cause dizziness, fatigue, or other central nervous system-related side effects.
• Pregnancy: Pregnant women or those planning to become pregnant should discuss all potential risks and benefits of using Tysabri 300mg injection with their healthcare provider. They will assess the risks and benefits of continuing the medication during pregnancy and discuss alternative treatments if necessary.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.